Omega Healthcare Investors (NYSE:OHI – Get Free Report) had its price target raised by equities research analysts at Wells Fargo & Company from $45.00 to $47.00 in a report released on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price target points to a potential upside of 5.49% from the company’s current price.
Other research analysts have also recently issued research reports about the company. Cantor Fitzgerald lifted their target price on Omega Healthcare Investors from $50.00 to $52.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Weiss Ratings upgraded shares of Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Friday, March 20th. UBS Group reaffirmed a “buy” rating and set a $52.00 price target on shares of Omega Healthcare Investors in a report on Friday, February 6th. The Goldman Sachs Group assumed coverage on shares of Omega Healthcare Investors in a research report on Friday, January 9th. They set a “buy” rating and a $54.00 price objective for the company. Finally, Jefferies Financial Group restated a “hold” rating and issued a $45.00 target price on shares of Omega Healthcare Investors in a research report on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, Omega Healthcare Investors currently has an average rating of “Moderate Buy” and a consensus price target of $48.00.
Check Out Our Latest Report on Omega Healthcare Investors
Omega Healthcare Investors Price Performance
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in OHI. Norges Bank bought a new position in Omega Healthcare Investors in the 4th quarter valued at approximately $156,166,000. Invesco Ltd. grew its holdings in Omega Healthcare Investors by 101.7% during the 3rd quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust’s stock worth $208,775,000 after acquiring an additional 2,493,877 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Omega Healthcare Investors during the 4th quarter worth approximately $93,476,000. Hudson Bay Capital Management LP acquired a new position in Omega Healthcare Investors in the 2nd quarter valued at approximately $71,312,000. Finally, Cbre Investment Management Listed Real Assets LLC raised its stake in shares of Omega Healthcare Investors by 327.5% during the fourth quarter. Cbre Investment Management Listed Real Assets LLC now owns 2,222,799 shares of the real estate investment trust’s stock valued at $98,559,000 after acquiring an additional 1,702,846 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.
Featured Stories
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
